88 related articles for article (PubMed ID: 17565410)
1. The use of oral antidiabetic agents in primary care.
Weekes AJ; Thomas MC
Aust Fam Physician; 2007 Jun; 36(6):477-80. PubMed ID: 17565410
[TBL] [Abstract][Full Text] [Related]
2. Discrepancies among consensus documents, guidelines, clinical practice and the legal framework for the treatment of type 2 diabetes mellitus patients.
del Pozo-Fernández C; Pardo-Ruiz C; Sánchez-Botella C; Blanes-Castañer V; López-Menchero R; Gisbert-Sellés C; Sánchez-Jodar C; Alvarez-Avellán L
Nefrologia; 2012 May; 32(3):367-73. PubMed ID: 22592422
[TBL] [Abstract][Full Text] [Related]
3. Age, renal dysfunction, cardiovascular disease, and antihyperglycemic treatment in type 2 diabetes mellitus: findings from the Renal Insufficiency and Cardiovascular Events Italian Multicenter Study.
Solini A; Penno G; Bonora E; Fondelli C; Orsi E; Trevisan R; Vedovato M; Cavalot F; Cignarelli M; Morano S; Ferrannini E; Pugliese G;
J Am Geriatr Soc; 2013 Aug; 61(8):1253-61. PubMed ID: 23889588
[TBL] [Abstract][Full Text] [Related]
4. Sitagliptin: a novel drug for the treatment of type 2 diabetes.
Choy M; Lam S
Cardiol Rev; 2007; 15(5):264-71. PubMed ID: 17700385
[TBL] [Abstract][Full Text] [Related]
5. Utilization of antidiabetic drugs in Hong Kong: relation to the common occurrence of antidiabetic drug-induced hypoglycemia amongst acute medical admissions and the relative prevalence of NIDDM.
Chan TY; Lee KK; Chan AW; Critchley JA
Int J Clin Pharmacol Ther; 1996 Jan; 34(1):43-6. PubMed ID: 8688996
[TBL] [Abstract][Full Text] [Related]
6. Optimizing antidiabetic treatment options for patients with type 2 diabetes mellitus and cardiovascular comorbidities.
Malesker MA
Pharmacotherapy; 2008 Feb; 28(2):193-206. PubMed ID: 18225965
[TBL] [Abstract][Full Text] [Related]
7. Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease.
Snyder RW; Berns JS
Semin Dial; 2004; 17(5):365-70. PubMed ID: 15461745
[TBL] [Abstract][Full Text] [Related]
8. Establishing pragmatic estimated GFR thresholds to guide metformin prescribing.
Shaw JS; Wilmot RL; Kilpatrick ES
Diabet Med; 2007 Oct; 24(10):1160-3. PubMed ID: 17672860
[TBL] [Abstract][Full Text] [Related]
9. Assessment and management of hypertension in patients with type 2 diabetes.
Thomas MC; Atkins R
Intern Med J; 2009 Mar; 39(3):143-9. PubMed ID: 18771428
[TBL] [Abstract][Full Text] [Related]
10. Variation in antidiabetic medication intensity among Medicare beneficiaries with diabetes mellitus.
Stuart B; Shaffer TJ; Simoni-Wastila LJ; Zuckerman IH; Quinn CC
Am J Geriatr Pharmacother; 2007 Sep; 5(3):195-208. PubMed ID: 17996659
[TBL] [Abstract][Full Text] [Related]
11. Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in Medicaid-enrolled patients with type 2 diabetes mellitus.
Balkrishnan R; Arondekar BV; Camacho FT; Shenolikar RA; Horblyuk R; Anderson RT
Clin Ther; 2007 Jun; 29(6 Pt 1):1306-15. PubMed ID: 18036392
[TBL] [Abstract][Full Text] [Related]
12. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
[TBL] [Abstract][Full Text] [Related]
13. Comparison of glycaemic control in patients with Type 2 diabetes on basal insulin and fixed combination oral antidiabetic treatment: results of a pilot study.
De Mattia G; Laurenti O; Moretti A
Acta Diabetol; 2009 Mar; 46(1):67-73. PubMed ID: 19030772
[TBL] [Abstract][Full Text] [Related]
14. [Use of oral hypoglycemic agents in patients with chronic kidney failure].
Libardi F; Sirolli V; Cappelli P; Bonomini M
G Ital Nefrol; 2009; 26(6):679-85. PubMed ID: 19918750
[TBL] [Abstract][Full Text] [Related]
15. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
[TBL] [Abstract][Full Text] [Related]
16. A comparison of select cardiovascular outcomes by antidiabetic prescription drug classes used to treat type 2 diabetes among Military Health System beneficiaries, fiscal year 2003-2006.
Casscells SW; Granger E; Swedorske J; Goldhammer R; Shaheen M; Dorris J; Hong A; Wiktor M
Am J Ther; 2008; 15(3):198-205. PubMed ID: 18496256
[TBL] [Abstract][Full Text] [Related]
17. Oral combination therapy: repaglinide plus metformin for treatment of type 2 diabetes.
Raskin P
Diabetes Obes Metab; 2008 Dec; 10(12):1167-77. PubMed ID: 18494804
[TBL] [Abstract][Full Text] [Related]
18. The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial.
Mellbin LG; Malmberg K; Norhammar A; Wedel H; Rydén L;
Eur Heart J; 2008 Jan; 29(2):166-76. PubMed ID: 18156614
[TBL] [Abstract][Full Text] [Related]
19. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
[TBL] [Abstract][Full Text] [Related]
20. Trends and influences on use of antidiabetic drugs in England, 1992-2003.
Walley T; Hughes D; Kendall H
Pharmacoepidemiol Drug Saf; 2005 Nov; 14(11):769-73. PubMed ID: 15768446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
